Hepatitis C Mortality Data
A study on hepatitis C virus-related mortality estimated that in mainland France in 2001:
the number of deaths associated with HCV was 3,618 (95% CI: 2,499–4,735), corresponding to a mortality rate of 6.1 per 100,000 inhabitants (95% CI: 4.2–8.0)
the number of deaths attributable to HCV was 2,646 (95% CI: 641–3,650), corresponding to a mortality rate of 4.5 per 100,000 inhabitants (95% CI: 2.8–6.2)
the stage of the disease at the time of death was at least cirrhosis in 95% of cases and hepatocellular carcinoma on cirrhosis in 33% of cases.
An analysis of data from the Program for the Medicalization of Information Systems (PMSI) estimated the number of deaths among patients with chronic hepatitis B at 21,164 during the 2004–2011 period, representing an overall mortality rate of 13.1%. Mortality was higher among men than among women (13.8% vs. 12.1%). More than 60% of deaths occurred among hospitalized patients with a complication.
article
6 September 2019
National estimate of mortality associated with and attributable to hepatitis C and hepatitis B in mainland France in 2001
article
6 September 2019
Prevalence, Morbidity, and Mortality Associated with Chronic Hepatitis B and C Among Hospitalized Patients in France, 2004–2011
GEODES
Track the trends in hepatitis C in France and in your region
In relation to
Hepatitis B and D
thematic dossier
Viral liver infections can be very severe; hepatitis B and D are transmitted through sexual contact, blood, and from mother to fetus. Vaccination and screening are the cornerstones of prevention.
HIV/AIDS
thematic dossier
HIV, or Human Immunodeficiency Virus, is a sexually transmitted human retrovirus. It weakens the immune system, and if left untreated, leads to AIDS.
Illegal drugs
thematic dossier
The use of illicit drugs exposes individuals to various health, social, and legal risks. In light of this major public health issue, prevention is essential.
